Form 4: NYT CEO Sells 51,949 Shares in Pre-Planned Transaction
Insider Transaction Report
Meredith A. Kopit Levien, President and CEO of The New York Times Company, sold 51,949 shares of Class A Common Stock for approximately $79.70 per share.
Summary
- Meredith A. Kopit Levien, President and CEO of The New York Times Company, executed a sale of Class A Common Stock.
- A total of 51,949 shares were disposed of on March 3, 2026.
- The shares were sold at a weighted average price of $79.702 per share, with prices ranging from $79.270 to $79.900.
- Following this transaction, Ms. Kopit Levien directly owns 229,362 shares of Class A Common Stock.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. While a large insider sale can sometimes raise questions, the disclosure of a Rule 10b5-1 plan suggests a pre-scheduled transaction rather than a reaction to new, undisclosed information.
Negatives
- A significant insider sale of 51,949 shares by the President and CEO could be perceived negatively by some investors, despite being pre-planned.
Industry Context
StockSavvy.ai notes that insider sales, even those executed under a Rule 10b5-1 plan, are common for executives managing personal finances, diversification, or tax planning. Such transactions in the media industry are typically viewed in the context of the company's overall performance and the executive's remaining stake.
Stakeholder Impact
- Shareholders: May interpret the sale as a signal, though the Rule 10b5-1 plan mitigates immediate concerns about management's confidence.
Key Dates
| Date | Description |
|---|---|
| 03/03/2026 | Date of transaction where 51,949 shares were sold. |
| 03/05/2026 | Date the Form 4 was filed with the SEC. |
Recommendation
holdThe sale by the CEO is a routine insider transaction executed under a pre-planned Rule 10b5-1 program, which typically indicates personal financial management rather than a change in outlook for the company. It does not provide new fundamental information to warrant a change in investment thesis, thus a 'hold' recommendation is appropriate.
Keywords
New York Times, NYT, Insider Sale, Meredith Kopit Levien, CEO, Stock Transaction, Form 4, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.